Interim report
Page 1
Financial Statements for the 2nd Quarter of the Fiscal Year Ending December 31 , 2021 KOBAYASHI PHARMACEUTICAL CO . , LTD . Summary of Financial Statements ( Japanese GAAP ) ( Consolidated ) Financial Results for the 2nd Quarter of the Fiscal Year Ending December 31 , 2021 July 29 , 2021 Listed exchanges : Tokyo Listed company name : Kobayashi Pharmaceutical Co. , Ltd. Code : 4967 URL : https://www.kobayashi.co.jp/english/index.html Representative officer : Akihiro Kobayashi , President & COO Contact : Satoshi Yamane , Tel : + 81-6-6222-0142 Expected date for submitting quarterly securities report : August 6 , 2021 Expected date for starting payment of dividends : September 9 , 2021 Preparation of supplementary documents for quarterly financial results : Yes Holding of an analyst meeting for quarterly financial results : Yes ( For analysts and investors ) Senior Executive Director & Senior General Manager , Corporate Headquarters ( Any fraction less than 1 million yen is rounded down to the nearest million yen . ) 1. Consolidated Results for 2nd Quarter of Fiscal Year Ending December 31 , 2021 ( January 1 , 2021 to June 30 , 2021 ) ( 1 ) Consolidated Operating Results ( accumulation ) Net sales Operating income Ordinary income Net income attributable to owners of the parent Net income per share Q2 of FY ending December 31 , 2021 67,052 millions of yen 1.3 % 10,240 11,091 7,881 100.84 yen ( % figures represent changes from same period in previous year ) Q2 of FY ended December 31 , 2020 66,180 millions of yen ( 4.5 ) % 10,220 11,029 8,218 ( 2 ) Consolidated Financial Position ( Note ) Comprehensive income Q2 of FY ending December 31 , 2021 : 11,331 million yen ( 100.6 % ) Q2 of FY ended December 31 , 2020 : 5,648 million yen ( -24.8 % ) 0.2 0.6 ( 4.1 ) Q2 of FY ending December 31 , 2021 239,352 millions of yen 190,553 79.6 % 0-1 105.14 yen ( 8.2 ) ( 5.2 ) 0.2 FY ended December 31 , 2020 238,366 millions of yen 182,583 76.6 % Total assets Net assets Shareholders ' equity ratio ( Reference ) Shareholders ' equity Q2 of FY ending December 31 , 2021 : 190,553 million yen FY ended December 31 , 2020 : 182,583 million yen